CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Shares withheld for taxes Chief Medical Officer gave up 10,819 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Shares withheld for taxes SVP Sales and Marketing gave up 2,714 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Grant or award SVP, Regulatory Affairs acquired 20,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
Page 7 of 35 · 689 filings